A new consensus statement by American Association of Clinical Endocrinology emphasizes lifestyle interventions and ...
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy ® (epinephrine ...
Tshiamo Maluleka-Disemelo emphasises the need for modernised governance frameworks to balance innovation with accountability ...
When it comes to promotion and tenure, don’t just describe your research—explain and quantify its impact.
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...
As an individual facing today’s wars and geopolitical complexity—witnessing so much suffering—I often feel powerless and sad; ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...
The populations with the greatest disparities are adolescents, Black and Hispanic patients, and those with public or no ...
Protean Funds Scandinavia shares October fund updates, key milestones, and market insights. Explore performance drivers and ...
Frankfurt is rapidly establishing itself as one of Europe's most dynamic AI hubs. During AI Week Frankfurt 2025, OpenAI, ...
Knorr-Bremse AG ( OTCPK:KNRRY) Q3 2025 Earnings Call October 29, 2025 8:00 PM EDT Welcome to Knorr-Bremse's conference call for the Financial Results of the Third Quarter 2025. [Operator Instructions] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback